Trastorn per dèficit d'atenció amb hiperactivitat (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Trastorn per dèficit d'atenció amb hiperactivitat" in Catalan language version.

refsWebsite

Global rank Catalan rank

16nih.gov

4^th place

7^th place

14doi.org

2^nd place

6^th place

2jamanetwork.com

2,650^th place

3,376^th place

1web.archive.org

1^st place

1xtec.cat

low place

48^th place

1thelancet.com

2,393^rd place

2,029^th place

1ccfundacions.cat

low place

1,966^th place

ccfundacions.cat

Coordinadora Catalana de Fundacions, Fundació Adana

doi.org

dx.doi.org

Biederman, J.; Faraone, S.V. «Attention-deficit hyperactivity disorder». Lancet, 366, 9481, 2005, pàg. 237-48. DOI: 10.1016/S0140-6736(05)66915-2. PMID: 16023516.
Okie, S. «ADHD in adults». N. Engl. J. Med., 354, 25, 2006, pàg. 2637-41. DOI: 10.1056/NEJMp068113.
Larson K, Russ SA, Kahn RS, Halfon N «Patterns of Comorbidity, Functioning, and Service Use for US Children With ADHD». Pediatrics, 127, 3, 2011, pàg. 462-70. DOI: 10.1542/peds.2010-0165. PMID: 21300675.
Faraone SV, Perlis RH, Doyle AE, et al. «Molecular genetics of attention-deficit/hyperactivity disorder». Biol. Psychiatry, 57, 11, 2005, pàg. 1313-23. DOI: 10.1016/j.biopsych.2004.11.024. PMID: 15950004.
NM Williams, I Zaharieva, A Martin, K Langley, K Mantripragada, R Fossdal et al. «Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis». The Lancet, 376, 9750, 2010, pàg. 1401-8. DOI: 10.1016/S0140-6736(10)61109-9 [Consulta: 9 maig 2023].
Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F et al. «Evaluating dopamine reward pathway in ADHD: clinical implications». JAMA, 302, 10, 2009, pàg. 1084-91. DOI: 10.1001/jama.2009.1308. PMC: 2958516. PMID: 19738093 [Consulta: 10 maig 2023].
Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ «Dopamine transporter density in patients with attention deficit hyperactivity disorder.». Lancet, 354, 9196, 1999, pàg. 2132-3. DOI: 10.1016/S0140-6736(99)04030-1. PMID: 10609822.
Rappley, MD «Clinical practice. Attention deficit-hyperactivity disorder». N. Engl. J. Med., 352, 2, 2005, pàg. 165-73. DOI: 10.1056/NEJMcp032387. PMID: 15647579.
Wolraich ML, Hagan JF, Allan C, Chan E, Davison D, Earls M, et al. «Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents». Pediatrics, 144, 4, 2019. DOI: 10.1542/peds.2019-2528. PMC: 7067282. PMID: 31570648 [Consulta: 11 maig 2023].
Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M et al. «Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial.». JAMA, 304, 8, 2010, pàg. 875-80. DOI: 10.1001/jama.2010.1192. PMID: 20736471 [Consulta: 11 maig 2023].
Peterson K, McDonagh MS, Fu R «Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.». Psychopharmacology, 197, 1, 2008, pàg. 1-11. DOI: 10.1007/s00213-007-0996-4. PMID: 18026719.
Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M «Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults». Cochrane Database Syst Rev, 6, 2011. DOI: 10.1002/14651858.CD007813.pub2. PMID: 21678370.
Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV «Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study.». Pediatrics, 124, 1, 2009, pàg. 71-8. DOI: 10.1542/peds.2008-3347. PMID: 19564285.
Wigal, S. B. «Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults». CNS Drugs, 23, 1, 2009, pàg. 21-31. DOI: 10.2165/00023210-200923000-00004. PMID: 19621975.

jamanetwork.com

Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F et al. «Evaluating dopamine reward pathway in ADHD: clinical implications». JAMA, 302, 10, 2009, pàg. 1084-91. DOI: 10.1001/jama.2009.1308. PMC: 2958516. PMID: 19738093 [Consulta: 10 maig 2023].
Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M et al. «Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial.». JAMA, 304, 8, 2010, pàg. 875-80. DOI: 10.1001/jama.2010.1192. PMID: 20736471 [Consulta: 11 maig 2023].

nih.gov

ncbi.nlm.nih.gov

Biederman, J.; Faraone, S.V. «Attention-deficit hyperactivity disorder». Lancet, 366, 9481, 2005, pàg. 237-48. DOI: 10.1016/S0140-6736(05)66915-2. PMID: 16023516.
Larson K, Russ SA, Kahn RS, Halfon N «Patterns of Comorbidity, Functioning, and Service Use for US Children With ADHD». Pediatrics, 127, 3, 2011, pàg. 462-70. DOI: 10.1542/peds.2010-0165. PMID: 21300675.
Castellanos FX, Lee PP, Sharp W, et al. «Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder». JAMA, 288, 14, 2002, pàg. 1740-8. PMID: 12365958.
Faraone SV, Perlis RH, Doyle AE, et al. «Molecular genetics of attention-deficit/hyperactivity disorder». Biol. Psychiatry, 57, 11, 2005, pàg. 1313-23. DOI: 10.1016/j.biopsych.2004.11.024. PMID: 15950004.
Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F et al. «Evaluating dopamine reward pathway in ADHD: clinical implications». JAMA, 302, 10, 2009, pàg. 1084-91. DOI: 10.1001/jama.2009.1308. PMC: 2958516. PMID: 19738093 [Consulta: 10 maig 2023].
Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ «Dopamine transporter density in patients with attention deficit hyperactivity disorder.». Lancet, 354, 9196, 1999, pàg. 2132-3. DOI: 10.1016/S0140-6736(99)04030-1. PMID: 10609822.
Rappley, MD «Clinical practice. Attention deficit-hyperactivity disorder». N. Engl. J. Med., 352, 2, 2005, pàg. 165-73. DOI: 10.1056/NEJMcp032387. PMID: 15647579.
Barkley RA, Guevremont DC, Anastopoulos AD, Fletcher KE «A comparison of three family therapy programs for treating family conflicts in adolescents with attention-deficit hyperactivity disorder». Journal of consulting and clinical psychology, 60, 3, 1992, pàg. 450-62. PMID: 1619099.
Wolraich ML, Hagan JF, Allan C, Chan E, Davison D, Earls M, et al. «Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents». Pediatrics, 144, 4, 2019. DOI: 10.1542/peds.2019-2528. PMC: 7067282. PMID: 31570648 [Consulta: 11 maig 2023].
Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M et al. «Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial.». JAMA, 304, 8, 2010, pàg. 875-80. DOI: 10.1001/jama.2010.1192. PMID: 20736471 [Consulta: 11 maig 2023].
Peterson K, McDonagh MS, Fu R «Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.». Psychopharmacology, 197, 1, 2008, pàg. 1-11. DOI: 10.1007/s00213-007-0996-4. PMID: 18026719.
Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M «Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults». Cochrane Database Syst Rev, 6, 2011. DOI: 10.1002/14651858.CD007813.pub2. PMID: 21678370.
Pritchard, D. «Attention deficit hyperactivity disorder in children». Clin Evid, 15, 2006, pàg. 331-44. PMID: 16973014.
Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV «Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study.». Pediatrics, 124, 1, 2009, pàg. 71-8. DOI: 10.1542/peds.2008-3347. PMID: 19564285.
Ratey JJ, Greenberg MS, Lindem KJ «Combination of treatments for attention deficit hyperactivity disorder in adults.». Nerv Ment Dis, 179, 11, 1991, pàg. 699-701. PMID: 1940895.
Wigal, S. B. «Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults». CNS Drugs, 23, 1, 2009, pàg. 21-31. DOI: 10.2165/00023210-200923000-00004. PMID: 19621975.

thelancet.com

NM Williams, I Zaharieva, A Martin, K Langley, K Mantripragada, R Fossdal et al. «Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis». The Lancet, 376, 9750, 2010, pàg. 1401-8. DOI: 10.1016/S0140-6736(10)61109-9 [Consulta: 9 maig 2023].

web.archive.org

«El trastorn per dèficit d'atenció amb hiperactivitat o sense.». Arxivat de l'original el 2015-02-24. [Consulta: 25 novembre 2014].

xtec.cat

«El trastorn per dèficit d'atenció amb hiperactivitat o sense.». Arxivat de l'original el 2015-02-24. [Consulta: 25 novembre 2014].